Clinical and therapeutic relevance of the metabolic oncogene fatty acid synthase in HER2+ breast cancer. [electronic resource]
Producer: 20180307Description: 687-698 p. digitalISSN:- 1699-5848
- 4-Butyrolactone -- analogs & derivatives
- Antineoplastic Agents -- pharmacology
- Apoptosis -- drug effects
- Breast Neoplasms -- drug therapy
- Cell Cycle -- drug effects
- Cell Line, Tumor
- Enzyme Inhibitors -- pharmacology
- Fatty Acid Synthase, Type I -- antagonists & inhibitors
- Female
- Gene Expression Regulation, Neoplastic -- drug effects
- Humans
- MCF-7 Cells
- Oncogenes -- genetics
- Prognosis
- Receptor, ErbB-2 -- drug effects
- Survival Analysis
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.